Sergio Estrada‐Parra

2.8k total citations
151 papers, 2.1k citations indexed

About

Sergio Estrada‐Parra is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Sergio Estrada‐Parra has authored 151 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 42 papers in Epidemiology and 41 papers in Infectious Diseases. Recurrent topics in Sergio Estrada‐Parra's work include Mycobacterium research and diagnosis (24 papers), Leprosy Research and Treatment (22 papers) and Tuberculosis Research and Epidemiology (16 papers). Sergio Estrada‐Parra is often cited by papers focused on Mycobacterium research and diagnosis (24 papers), Leprosy Research and Treatment (22 papers) and Tuberculosis Research and Epidemiology (16 papers). Sergio Estrada‐Parra collaborates with scholars based in Mexico, United States and United Kingdom. Sergio Estrada‐Parra's co-authors include Iris Estrada‐García, Rommel Chacón‐Salinas, O Rojas-Espinosa, Jeanet Serafín‐López, Sirenia González‐Pozos, Lenin Pavón, Marcia Campillo-Navarro, Ricardo Mondragón‐Flores, Sonia Mayra Pérez‐Tapia and Rogélio Hernández‐Pando and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Sergio Estrada‐Parra

144 papers receiving 1.9k citations

Peers

Sergio Estrada‐Parra
William P. Lafuse United States
Francesco Ria Italy
Giulia Freer Italy
Nancy E. Street United States
Anna Nilsson Sweden
Ahmed Metwali United States
Mark S. Pasternack United States
P. C. J. Leijh Netherlands
Robin M. Yates Canada
Nicole Israël France
William P. Lafuse United States
Sergio Estrada‐Parra
Citations per year, relative to Sergio Estrada‐Parra Sergio Estrada‐Parra (= 1×) peers William P. Lafuse

Countries citing papers authored by Sergio Estrada‐Parra

Since Specialization
Citations

This map shows the geographic impact of Sergio Estrada‐Parra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Estrada‐Parra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Estrada‐Parra more than expected).

Fields of papers citing papers by Sergio Estrada‐Parra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Estrada‐Parra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Estrada‐Parra. The network helps show where Sergio Estrada‐Parra may publish in the future.

Co-authorship network of co-authors of Sergio Estrada‐Parra

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Estrada‐Parra. A scholar is included among the top collaborators of Sergio Estrada‐Parra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Estrada‐Parra. Sergio Estrada‐Parra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gómez‐Martín, Diana, Jiram Torres‐Ruiz, José Francisco Muñóz-Valle, et al.. (2025). Mast cell activation signature as a potential biomarker in COVID-19. Immunology Letters. 275. 107026–107026.
2.
Medina‐Rivero, Emilio, et al.. (2021). Consistency of a dialyzable leucocyte extract manufactured at GMP facilities by nuclear magnetic resonance spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 196. 113940–113940. 4 indexed citations
3.
Mellado‐Sánchez, Gabriela, Marco A. Velasco‐Velázquez, Lenin Pavón, et al.. (2019). Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release. Molecules. 24(19). 3426–3426. 1 indexed citations
4.
Ibáñez-Hernández, Miguel Ángel, Luvia Enid Sánchez‐Torres, Jorge Barrios‐Payán, et al.. (2019). <p>Extracellular vesicles released by J774A.1 macrophages reduce the bacterial load in macrophages and in an experimental mouse model of tuberculosis</p>. International Journal of Nanomedicine. Volume 14. 6707–6719. 22 indexed citations
5.
Medina‐Rivero, Emilio, Lenin Pavón, Gabriela Mellado‐Sánchez, et al.. (2017). Transferon™, a peptide mixture with immunomodulatory properties is not immunogenic when administered with various adjuvants. Journal of Immunotoxicology. 14(1). 169–177. 3 indexed citations
6.
Campillo-Navarro, Marcia, Luis Donis‐Maturano, Jeanet Serafín‐López, et al.. (2016). Listeria monocytogenes induces mast cell extracellular traps. Immunobiology. 222(2). 432–439. 46 indexed citations
7.
Serafín‐López, Jeanet, Iris Estrada‐García, Sergio Estrada‐Parra, et al.. (2015). Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus. Journal of Immunology Research. 2015. 1–15. 8 indexed citations
8.
Robledo‐Avila, Frank, Mayra Pérez-Tapia, Alberto Yairh Limón-Flores, et al.. (2013). Low-Dose Amphotericin B and Murine Dialyzable Spleen Extracts Protect against SystemicCandidaInfection in Mice. SHILAP Revista de lepidopterología. 2013. 1–7. 6 indexed citations
9.
Estrada‐Parra, Sergio, et al.. (2010). Inmunofenotipo de células mononucleares aisladas de calostro humano. Perinatología y Reproducción Humana. 24(4). 228–235.
10.
Hernández, Marı́a Eugenia, Daniel Martínez‐Fong, Mayra Pérez-Tapia, et al.. (2009). Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder. European Neuropsychopharmacology. 20(2). 88–95. 48 indexed citations
11.
Serafín‐López, Jeanet, et al.. (2009). Péptidos antimicrobianos: péptidos con múltiples funciones. 18(1). 16–29. 6 indexed citations
12.
Silva‐García, Raúl, et al.. (2009). Effect of Mycobacterium tuberculosis trapped in NETs on macrophage proinflammatory response (134.83). The Journal of Immunology. 182(Supplement_1). 134.83–134.83. 2 indexed citations
13.
Chávez, Raúl, et al.. (2007). Adjuvant Treatment Using Dialyzable Leukocyte Extract for Herpetic Keratitis. Investigative Ophthalmology & Visual Science. 48(13). 2666–2666. 1 indexed citations
14.
Robledo‐Avila, Frank, Isabel Wong‐Baeza, Jeanet Serafín‐López, et al.. (2007). Human dialyzable leukocyte extracts (DLE) have ligands for TLR- 2 but not for TLR-4 (49.34). The Journal of Immunology. 178(1_Supplement). S89–S89. 1 indexed citations
15.
Pérez‐Tapia, Sonia Mayra, et al.. (2007). Use of dialyzable leukocyte extracts (DLE) in patients with severe sepsis (49.35). The Journal of Immunology. 178(1_Supplement). S90–S90. 1 indexed citations
16.
Estrada‐Parra, Sergio, et al.. (2002). El efecto terapéutico del factor de transferencia en el tratamiento de pacientes con dermatitis atópica grave. 11(1). 9–11. 1 indexed citations
17.
Estrada‐Parra, Sergio, et al.. (2001). Immunomodulatory properties of Mycoplasma pulmonis. International Immunopharmacology. 1(9-10). 1679–1688. 10 indexed citations
18.
Estrada‐Parra, Sergio, et al.. (1985). Criptosporidiosis asociada con SIDA: informe de un caso. 5(2). 33–36. 1 indexed citations
19.
Rojas-Espinosa, O, et al.. (1985). Biochemical alterations in the serum of armadillos (Dasypus novemcinctus) infected with Mycobacterium leprae. A preliminary report.. PubMed. 53(2). 262–8. 1 indexed citations
20.
Alarcón-Segovia, D, et al.. (1970). The range and specificity of antinuclear antibodies in systemic lupus erythematosus.. PubMed Central. 6(4). 557–71. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William P. Lafuse Breakdown of academic impact, for papers by Francesco Ria Breakdown of academic impact, for papers by Giulia Freer Breakdown of academic impact, for papers by Nancy E. Street Breakdown of academic impact, for papers by Anna Nilsson Breakdown of academic impact, for papers by Ahmed Metwali Breakdown of academic impact, for papers by Mark S. Pasternack Breakdown of academic impact, for papers by P. C. J. Leijh Breakdown of academic impact, for papers by Robin M. Yates Breakdown of academic impact, for papers by Nicole Israël
Rankless by CCL
2026